000 03731nam a2200385 c 4500
988 _aSpringer_BiomedLife_2019
999 _c115560
_d115560
_x1
001 115560
003 ESmaUEC
005 20230104140051.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 190829s2019 gw a o |||| 0|eng d
020 _a9783030247256
024 7 _a10.1007/978-3-030-24725-6
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC270
_b2019 EB
100 1 _aDakubo, Gabriel D.
_eautor
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_996747
245 1 0 _aCancer Biomarkers in Body Fluids :
_bBiomarkers in Proximal Fluids
_cby Gabriel D. Dakubo.
250 _a1st ed. 2019.
264 1 _aCham
_bSpringer International Publishing
_c2019
300 _a1 recurso en línea (XXI, 296 páginas)
_b 11 ilustraciones a color
336 _aTexto
_btxt
_2rdacontent
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aBiomedical and Life Sciences (Springer-11642)
505 0 _a1. Melanoma Biomarkers in Exfoliated Cells -- 2. Head and Neck Cancer Biomarkers in Saliva -- 3. Lung Cancer Biomarkers in Lung Fluids -- 4. Breast Cancer Biomarkers in Breast Fluids -- 5. Gastric Cancer Biomarkers in Gastric Fluid -- 6. Colorectal Cancer Biomarkers in Stool -- 7. Hepatobiliary Cancer Biomarkers in Bile -- 8. Pancreatic Cancer Biomarkers in Pancreatic Juice -- 9. Renal Cancer Biomarkers in Urine -- 10. Bladder Cancer Biomarkers in Urine -- 11. Prostate Cancer Biomarkers in Prostatic Fluid -- 12. Testicular Cancer Biomarkers in Seminal Fluid -- 13. Ovarian Cancer Biomarkers in Peritoneal Fluid -- 14. Endometrial Cancer Biomarkers in Menstrual Fluid -- 15. Cervical and Vulvar Cancer Biomarkers in Exfoliated Cells -- 16. Brain Cancer Biomarkers in Cerebrospinal Fluid -- 17. Hematologic Cancer Biomarkers in Blood -- 18. The Body Fluid Microbiome and Cancer -- 19. Biomarkers in Interstitial Fluids of Cancer Cells.
520 3 _aThe ability to measure and monitor cancer biomarkers in "body fluid biopsy" should greatly impact oncologic practice. "Biomarkers in Proximal Fluids", the third of the "Cancer Biomarkers in Body Fluids" series details cancer signatures in none or minimally circulating body fluids including saliva, sputum, bronchoalveolar lavage fluid, exhaled breath condensate, nipple aspirate fluid, gastric and pancreatic juice, stool, urine, and prostatic, peritoneal and cerebrospinal fluid. These fluids are enriched with biomarkers, especially those emanating from cells of the proximal tissue. Chapter 1 examines the global burden of cancer and the need for regional efforts at primary prevention, early detection and patient care. Chapters 2-12 address tissue-specific biomarkers in associated body fluids. The tumor interstitial fluid as a microenvironment rich in cancer biomarkers is detailed in chapter 13, while chapter 14 looks at the human body fluid microbiome and its evolving role in cancer. Commercially available assays using proximal fluids are examined at the end of the respective chapters. This book complements its predecessors and is equally useful to oncologists, cancer researchers, clinicians, medical students, nurses, diagnostic laboratory and pharmaceutical industry personnel.
650 7 _2embne
_9182544
_aCáncer
_xDiagnóstico
776 0 8 _iPrinted edition:
_z9783030247232
776 0 8 _iPrinted edition:
_z9783030247249
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-24725-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _aSI
_cm
_dz
_feng
_ggw
_h0
_b12/2019
_ek
_zSI